Emerging hematological targets and therapy for cardiovascular disease: From bench to bedside

Atherosclerotic cardiovascular disease is the leading cause of death and a major part of its pathophysiology remains obscure. Some hematological targets have been related to the development and clinical outcome of this disease, especially soluble cytokines, leukocytes, red blood cells, hemostatic factors and platelets, and bone-marrow vascular progenitors. These emerging factors may be modulated by current antiatherosclerotic pharmacotherapy, target-designed novel drugs or progenitor cell therapy. The aim of current review article is to comprehensively review the role of these antiatherosclerotic targets and therapy.

• Publication year

  2008

• Venue

  Biologics : targets & therapy

• Publication date

  2008-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2147/BTT.S2911PMID 19707371PMCID 2721378
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cellular Pathology: As Based Upon Physiological and Pathological Histology. Twenty Lectures Delivered in the Pathological Institute of Berlin During the Months of February, March and April, 1858

  2009cited by this paper
• Protective Role of CXC Receptor 4/CXC Ligand 12 Unveils the Importance of Neutrophils in Atherosclerosis

  2008cited by this paper
• Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?

  2008cited by this paper
• Contemporary Reviews in Cardiovascular Medicine Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases

  2008cited by this paper
• Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II.

  2008cited by this paper
• Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial.

  2007cited by this paper
• Smooth Muscle Cells Healing Atherosclerotic Plaque Disruptions Are of Local, Not Blood, Origin in Apolipoprotein E Knockout Mice

  2007cited by this paper
• The Peroxisome Proliferator–Activated Receptor-γ Agonist Pioglitazone Increases Number and Function of Endothelial Progenitor Cells in Patients With Coronary Artery Disease and Normal Glucose Tolerance

  2007cited by this paper
• Endothelial Progenitor Cells, Cardiovascular Risk Factors, Cytokine Levels and Atherosclerosis – Results from a Large Population-Based Study

  2007influential reference
• Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study).

  2007cited by this paper
• FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.

  2007cited by this paper
• Individual Variation of Scavenger Receptor Expression in Human Macrophages with Oxidized Low-Density Lipoprotein Is Associated with a Differential Inflammatory Response1

  2007cited by this paper
• Beneficial effects of 1-year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study

  2007cited by this paper
• The microenvironment can shift erythrocytes from a friendly to a harmful behavior: pathogenetic implications for vascular diseases.

  2007cited by this paper
• Plasma Interleukin-6 and Tumor Necrosis Factor-α Can Predict Coronary Endothelial Dysfunction in Hypertensive Patients

  2007cited by this paper
• Importance of CXC Chemokine Receptor 2 in the Homing of Human Peripheral Blood Endothelial Progenitor Cells to Sites of Arterial Injury

  2007influential reference
• Evidence that intracoronary-injected CD133+ peripheral blood progenitor cells home to the myocardium in chronic postinfarction heart failure.

  2007influential reference
• Attenuation of cardiac remodelling by endocardial injection of erythropoietin: ultrasonic strain-rate imaging in a model of hibernating myocardium.

  2007cited by this paper
• Effects of exercise training on endothelial progenitor cells in patients with chronic heart failure.

  2007cited by this paper
• AMD3100 Mobilizes Endothelial Progenitor Cells in Mice, But Inhibits Its Biological Functions by Blocking an Autocrine/Paracrine Regulatory Loop of Stromal Cell Derived Factor-1 In Vitro

  2007cited by this paper
• Thiazolidinediones and cardiovascular outcomes in older patients with diabetes.

  2007cited by this paper
• Two types of circulating endothelial progenitor cells in patients receiving long term therapy by HMG-CoA reductase inhibitors.

  2007cited by this paper
• Microvascular endothelial cells express a phosphatidylserine receptor: a functionally active receptor for phosphatidylserine-positive erythrocytes.

  2007cited by this paper
• Comparison of characteristics of future myocardial infarctions in women with baseline high versus baseline low levels of high-sensitivity C-reactive protein.

  2007cited by this paper
• Inhibition of 3-Hydroxy-3-Methylglutaryl Coenzyme A (HMG CoA) Reductase Blunts Factor VIIa/Tissue Factor and Prothrombinase Activities via Effects on Membrane Phosphatidylserine

  2007cited by this paper
• Transcoronary Transplantation of Functionally Competent BMCs Is Associated With a Decrease in Natriuretic Peptide Serum Levels and Improved Survival of Patients With Chronic Postinfarction Heart Failure: Results of the TOPCARE-CHD Registry

  2007influential reference
• Biphasic effect of pioglitazone on isolated human endothelial progenitor cells: Involvement of peroxisome proliferator-activated receptor-γ and transforming growth factor-β1

  2007cited by this paper
• Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma.

  2007cited by this paper
• Association of Leukocyte Count With Progression of Aortic Atheroma in Stroke/Transient Ischemic Attack Patients

  2007cited by this paper
• Improved clinical outcome after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial.

  2007influential reference
• Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis.

  2007cited by this paper
• Endothelial Progenitor Cell Mobilization and Increased Intravascular Nitric Oxide in Patients Undergoing Cardiac Rehabilitation

  2007cited by this paper
• Haptoglobin Genotype Is a Determinant of Iron, Lipid Peroxidation, and Macrophage Accumulation in the Atherosclerotic Plaque

  2007cited by this paper
• Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials.

  2007cited by this paper
• The additive antiplatelet action of clopidogrel in patients with coronary artery disease treated with aspirin

  2007cited by this paper
• Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment.

  2007influential reference
• Endothelial-to-mesenchymal transition contributes to cardiac fibrosis

  2007cited by this paper
• TGF-beta1: a novel target for cardiovascular pharmacology.

  2007influential reference
• Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels.

  2007cited by this paper
• Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure.

  2007cited by this paper
• The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study.

  2007cited by this paper
• A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.

  2006cited by this paper
• Myocardial Homing of Nonmobilized Peripheral‐Blood CD34+ Cells After Intracoronary Injection

  2006influential reference
• Neovascularization and cardiac repair by bone marrow-derived stem cells.

  2006cited by this paper
• Abstract 1653: Sirolimus Accelerates Senescence of Endothelial Progenitor Cells through Telomerase Inactivation

  2006cited by this paper
• A Single Bolus of a Long-acting Erythropoietin Analogue Darbepoetin Alfa in Patients with Acute Myocardial Infarction: A Randomized Feasibility and Safety Study

  2006cited by this paper
• Effects of granulocyte-colony-stimulating factor on mobilization of bone-marrow-derived stem cells after myocardial infarction in humans

  2006influential reference
• Intracoronary Bone Marrow Cell Transfer After Myocardial Infarction: Eighteen Months’ Follow-Up Data From the Randomized, Controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) Trial

  2006influential reference
• The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease.

  2006cited by this paper
• The immune response in atherosclerosis: a double-edged sword

  2006cited by this paper
• Number and Function of Endothelial Progenitor Cells as a Marker of Severity for Diabetic Vasculopathy

  2006cited by this paper
• Inhibition of cyclooxygenase (COX)-2 affects endothelial progenitor cell proliferation.

  2006cited by this paper
• Blood Monocytes Mimic Endothelial Progenitor Cells

  2006cited by this paper
• Hematopoietic colony stimulating factors in cardiovascular and pulmonary remodeling: promoters or inhibitors?

  2006cited by this paper
• Intracoronary infusion of autologous bone marrow cells and left ventricular function after acute myocardial infarction: a meta-analysis

  2006cited by this paper
• Effects of Granulocyte Colony Simulating Factor on Functional Activities of Endothelial Progenitor Cells in Patients With Chronic Ischemic Heart Disease

  2006cited by this paper
• Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.

  2006influential reference
• Stem Cell Mobilization Induced by Subcutaneous Granulocyte-Colony Stimulating Factor to Improve Cardiac Regeneration After Acute ST-Elevation Myocardial Infarction: Result of the Double-Blind, Randomized, Placebo-Controlled Stem Cells in Myocardial Infarction (STEMMI) Trial

  2006cited by this paper
• Cardiac cell therapy--mixed results from mixed cells.

  2006cited by this paper
• Plasma very-low-density lipoprotein, low-density lipoprotein, and high-density lipoprotein oxidative modification induces procoagulant profiles in endogenous hypertriglyceridemia.

  2006cited by this paper
• Aging Impairs the Beneficial Effect of Granulocyte Colony–Stimulating Factor and Stem Cell Factor on Post–Myocardial Infarction Remodeling

  2006cited by this paper
• Characterization of smooth muscle-like cells in circulating human peripheral blood.

  2006cited by this paper
• In vitro isolation of circulating endothelial progenitor cells is related to the high density lipoprotein plasma levels.

  2006cited by this paper
• Enalapril increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system.

  2006influential reference
• Narrative Review: Assessment of C-Reactive Protein in Risk Prediction for Cardiovascular Disease

  2006cited by this paper
• Erythropoietin-Mobilized Endothelial Progenitors Enhance Reendothelialization via Akt–Endothelial Nitric Oxide Synthase Activation and Prevent Neointimal Hyperplasia

  2006cited by this paper
• Effects of aspirin on number, activity and inducible nitric oxide synthase of endothelial progenitor cells from peripheral blood

  2006cited by this paper
• Myocardial ischemia and right ventricular dysfunction in adult patients with sickle cell disease.

  2006cited by this paper
• Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial.

  2006cited by this paper
• Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial.

  2006cited by this paper
• Cardiovascular Death and the Metabolic Syndrome

  2006influential reference
• Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus.

  2006cited by this paper
• Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.

  2006cited by this paper
• Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion.

  2006cited by this paper
• Circulating endothelial progenitor cells predict coronary artery disease severity.

  2006cited by this paper
• Endothelial progenitors: a new Tower of Babel?

  2006cited by this paper
• Intracoronary Infusion of CD133+ and CD133−CD34+ Selected Autologous Bone Marrow Progenitor Cells in Patients with Chronic Ischemic Cardiomyopathy: Cell Isolation, Adherence to the Infarcted Area, and Body Distribution

  2006influential reference
• Th1/Th2 Imbalance, Measured by Circulating and Intracytoplasmic Inflammatory Cytokines – Immunological Alterations in Acute Coronary Syndrome and Stable Coronary Artery Disease

  2006cited by this paper
• The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart.

  2006cited by this paper
• Circulating endothelial progenitor cells in multiple myeloma: implications and significance.

  2005cited by this paper
• C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation.

  2005cited by this paper
• Transfer of Endothelial Progenitor and Bone Marrow Cells Influences Atherosclerotic Plaque Size and Composition in Apolipoprotein E Knockout Mice

  2005cited by this paper
• Platelets and chemokines in atherosclerosis: partners in crime.

  2005cited by this paper
• [Effects of stem-cell mobilization with recombinant human granulocyte colony stimulating factor in patients with percutaneously revascularized acute anterior myocardial infarction].

  2005cited by this paper
• Rethinking the “Diseases of Affluence” Paradigm: Global Patterns of Nutritional Risks in Relation to Economic Development

  2005cited by this paper
• [Prognostic value of white blood cell count in acute myocardial infarction: long-term mortality].

  2005cited by this paper
• Compromised arterial function in human type 2 diabetic patients.

  2005influential reference
• Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study.

  2005cited by this paper
• Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation model.

  2005influential reference
• JTT-130, a microsomal triglyceride transfer protein (MTP) inhibitor lowers plasma triglycerides and LDL cholesterol concentrations without increasing hepatic triglycerides in guinea pigs

  2005cited by this paper
• Mechanisms of erythropoietin‐mediated cardioprotection during ischemia‐reperfusion injury: role of protein kinase C and phosphatidylinositol 3‐kinase signaling

  2005cited by this paper
• Oxidized Phospholipids Trigger Atherogenic Inflammation in Murine Arteries

  2005cited by this paper
• Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte–colony‐stimulating factor by single‐dose administration of AMD3100, a CXCR4 antagonist

  2005cited by this paper
• Reduced Number of Circulating Endothelial Progenitor Cells Predicts Future Cardiovascular Events: Proof of Concept for the Clinical Importance of Endogenous Vascular Repair

  2005cited by this paper
• Atherothrombosis and high-risk plaque: part I: evolving concepts.

  2005influential reference
• Endurance training increases the number of endothelial progenitor cells in patients with cardiovascular risk and coronary artery disease.

  2005cited by this paper
• Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress

  2005cited by this paper
• The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone.

  2005cited by this paper
• Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function.

  2005cited by this paper
• Endothelial‐like cells expanded from CD34+ blood cells improve left ventricular function after experimental myocardial infarction

  2005cited by this paper

• Erythrocyte functional status and lipid profile of coal mine workers of West Bengal, India

  2014cites this paper